Phase I Study of [<sup>68</sup>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)Odrade Gondry, Marleen Keyaerts, Denis Schallier et al.|Journal of Nuclear Medicine|2023Cited by 45
The Prognostic Value of CD206 in Solid Malignancies: A Systematic Review and Meta-AnalysisJens Debacker, Wouter Huvenne, Odrade Gondry et al.|Cancers|2021Cited by 40
Phase II Trial Assessing the Repeatability and Tumor Uptake of [<sup>68</sup>Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast CarcinomaOdrade Gondry, Marleen Keyaerts, Vicky Caveliers et al.|Journal of Nuclear Medicine|2024Cited by 40
68GaNOTA-anti-MMR-Nb for PET/CT assessment of protumorigenic macrophages in patients with solid tumors: preliminary results of a phase I clinical trialOdrade Gondry, Marleen Keyaerts, Catarina Xavier et al.|Unknown|2020Cited by 1
Abstract P3-02-05: Assessment of repeatability and uptake quantification of 68GaNOTA-anti-HER2 sdAb PET/CT in patients with locally advanced or metastatic breast cancerOdrade Gondry, Marleen Keyaerts, Vicky Caveliers et al.|Cancer Research|2022Cited by 0